Etsuko Kumagai, Kazuhiro Furumachi, Akihiro Kurihara, Ken Hosokawa, Keiko Hosohata, Shinji Takai. Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial. International Journal of Nephrology. 2023. 2023. 1-11
Keiko Hosohata. Impact of medication adherence on renal denervation trials in resistant hypertensive patients. Hypertens Res. 2023. 46. 10. 2419-2420
Toshinori Hirai, Shun Ueda, Toru Ogura, Kan Katayama, Kaoru Dohi, Keiko Hosohata, Takahiko Aoyama, Yoshiaki Matsumoto, Takuya Iwamoto. Hyperkalemia by eplerenone or esaxerenone in the presence or absence of clarithromycin in hypertensive patients: a retrospective observational cohort study. Journal of Hypertension. 2023. 41. 4. 580-586
Iku Niinomi, Saki Oyama, Ayaka Inada, Tomohito Wakabayashi, Tatsuya Iida, Hiroko Kambara, Mayako Uchida, Yukako Sano, Keiko Hosohata. Current Status of Adverse Event Profile of Cyclosporine in Kidney, Stem Cell, and Heart Transplantations Using the Japanese Pharmacovigilance Database. Cureus. 2022. 14. 9. e29383
Takeo Hata, Atsushi Hirata, Ryosuke Ota, Keiko Hosohata, Masami Nishihara, Masashi Neo, Takahiro Katsumata. Biologic disease-modifying and other anti-rheumatic drugs use in patients with moderate-to-severe juvenile idiopathic arthritis based on a Japanese nationwide claims database. Ther Clin Risk Manag. 2022. 18. 843-853